Cardiol Therapeutics Inc.

NASDAQ: CRDL · Real-Time Price · USD
1.32
-0.02 (-1.49%)
At close: Aug 15, 2025, 2:44 PM

Cardiol Therapeutics Ratios and Metrics

Financials in CAD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
PE Ratio
-3.59 -2.56 -1.4 -3.22
PEG Ratio
-0.23 0.25 0.04 -0.56
PS Ratio
n/a n/a n/a 1.29K
PB Ratio
5.33 2.55 0.83 1.34
P/FCF Ratio
-5.26 -2.85K -1.58 -4.32
P/OCF Ratio
-5.26 -2.86K -1.59 -4.33
OCF/S Ratio
n/a n/a n/a -299.02
Debt / Equity Ratio
0.01 0.01 0.00 0.00
Quick Ratio
4.52 4.36 6.27 7.53
Current Ratio
4.52 4.36 6.27 7.53
Asset Turnover
n/a n/a n/a 0.00
Interest Coverage
n/a n/a n/a n/a
Return on Equity
-1.48 -1 -0.59 -0.41
Return on Assets
-1.15 -0.77 -0.5 -0.36
Return on Invested Capital
-1.62 -1.05 -0.64 -0.47
Dividend Yield
n/a n/a n/a n/a
Payout Ratio
n/a n/a n/a n/a
Gross Profit Margin
n/a n/a n/a 1.00
Net Profit Margin
n/a n/a n/a -401.7
Pretax Profit Margin
n/a n/a n/a -401.7
Operating Profit Margin
n/a n/a n/a -577.36
FCF Margin
n/a n/a n/a n/a
EBITDA Margin
n/a n/a n/a -488.12